Avalo Therapeutics (AVTX) Earnings (2014 - 2025)
Avalo Therapeutics (AVTX) earnings from Sep 30, 2014 to Dec 31, 2025. The TTM Avalo Therapeutics (AVTX) earnings is -$78M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Earnings
Quarterly Earnings
Avalo Therapeutics (AVTX) Earnings CAGR table
| Period | CAGR |
|---|---|
| 3 Years TTM | +23.38% |
| 5 Years TTM | +4.27% |
| 10 Years TTM | +22.26% |
| All Time TTM | +26.83% |
Annual Earnings change of Avalo Therapeutics (AVTX)
| Year | Earnings | Change |
|---|---|---|
| 2025 | -$78M | +122.77% |
| 2024 | -$35M | +11.38% |
| 2023 | -$32M | -24.29% |
| 2022 | -$42M | -50.63% |
| 2021 | -$84M | +32.88% |
| 2020 | -$64M | +295.15% |
| 2019 | -$16M | -59.88% |
| 2018 | -$40M | -437.41% |
| 2017 | $12M | -172.07% |
| 2016 | -$16M | +57.01% |
| 2015 | -$10M | -34.68% |
| 2014 | -$16M | +23.07% |
| 2013 | -$13M | N/A |
Comparison Avalo Therapeutics (AVTX) five years earnings CAGR with competitors
Avalo Therapeutics (AVTX) five years earnings CAGR is 16.29%.